Factors Associated with Malignancy in Patients with Maximal Thyroid Nodules ≥2 Cm

References

• Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of endocrinology, and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules–2016 Update. Endocr Pract. 2016;22(5):622–639.27167915
   PubMed Web of Science ®Google Scholar
• Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The diagnosis and management of thyroid nodules: a review. JAMA. 2018;319(9):914–924. doi:10.1001/jama.2018.089829509871
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.26462967
   PubMed Web of Science ®Google Scholar
• Yan KL, Li S, Tseng CH, et al. Rising incidence and incidence-based mortality of thyroid cancer in California, 2000–2017. J Clin Endocrinol Metab. 2020;105(6):1770–1777. doi:10.1210/clinem/dgaa121
   Web of Science ®Google Scholar
• Al-Lawati NA, Shenoy SM, Al-Bahrani BJ, Al-Lawati JA. Increasing thyroid cancer incidence in oman: a joinpoint trend analysis. Oman Med J. 2020;35(1):e98. doi:10.5001/omj.2020.1632095279
   PubMedGoogle Scholar
• Shulin JH, Aizhen J, Kuo SM, Tan WB, Ngiam KY, Parameswaran R. Rising incidence of thyroid cancer in Singapore not solely due to micropapillary subtype. Ann R Coll Surg Engl. 2018;100(4):295–300. doi:10.1308/rcsann.2018.000429543059
   PubMed Web of Science ®Google Scholar
• Sanabria A, Kowalski LP, Shah JP, et al. Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis. Head Neck. 2018;40(4):855–866. doi:10.1002/hed.2502929206325
   PubMed Web of Science ®Google Scholar
• Al-Ghanimi IA, Al-Sharydah AM, Al-Mulhim S, et al. Diagnostic accuracy of ultrasonography in classifying thyroid nodules compared with fine-needle aspiration. Saudi J Med Med Sci. 2020;8(1):25–31. doi:10.4103/sjmms.sjmms_126_1831929775
   PubMed Web of Science ®Google Scholar
• Wang J, Liu J, Liu Z. Impact of ultrasound-guided fine needle aspiration cytology for diagnosis of thyroid nodules. Medicine (Baltimore). 2019;98(38):e17192. doi:10.1097/MD.000000000001719231567964
   PubMed Web of Science ®Google Scholar
• Feldkamp J, Fuhrer D, Luster M, Musholt TJ, Spitzweg C, Schott M. Fine needle aspiration in the investigation of thyroid nodules. Dtsch Arztebl Int. 2016;113(20):353–359. doi:10.3238/arztebl.2016.035327294815
   PubMed Web of Science ®Google Scholar
• Li JW, Chang C, Chen JY, Shi ZT, Chen M. Nodule size effect on diagnostic performance of ultrasonography and computed tomography for papillary thyroid carcinoma. Curr Med Imaging Rev. 2019;15(5):489–495. doi:10.2174/157340561466618042514214132008556
   PubMed Web of Science ®Google Scholar
• Aydogan BI, Sahin M, Ceyhan K, et al. The influence of thyroid nodule size on the diagnostic efficacy and accuracy of ultrasound guided fine-needle aspiration cytology. Diagn Cytopathol. 2019;47(7):682–687. doi:10.1002/dc.2417030861335
   PubMed Web of Science ®Google Scholar
• Nam SJ, Kwak JY, Moon HJ, Yoon JH, Kim EK, Koo JS. Large (>/=3cm) thyroid nodules with benign cytology: can Thyroid Imaging Reporting and Data System (TIRADS) help predict false-negative cytology? PLoS One. 2017;12(10):e0186242. doi:10.1371/journal.pone.018624229023564
   PubMed Web of Science ®Google Scholar
• Boucek J, Kastner J, Skrivan J, et al. Occult thyroid carcinoma. Acta Otorhinolaryngol Ital. 2009;29(6):296–304.20463833
   PubMed Web of Science ®Google Scholar
• Pensabene M, Stanzione B, Cerillo I, et al. It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature. BMC Cancer. 2018;18(1):146. doi:10.1186/s12885-018-4054-x29409458
   PubMed Web of Science ®Google Scholar
• Cavallo A, Johnson DN, White MG, et al. Thyroid nodule size at ultrasound as a predictor of malignancy and final pathologic size. Thyroid. 2017;27(5):641–650. doi:10.1089/thy.2016.033628052718
   PubMed Web of Science ®Google Scholar
• Zhao L, Yan H, Pang P, et al. Thyroid nodule size calculated using ultrasound and gross pathology as predictors of cancer: a 23-year retrospective study. Diagn Cytopathol. 2019;47(3):187–193. doi:10.1002/dc.2406830499203
   PubMed Web of Science ®Google Scholar
• Raparia K, Min SK, Mody DR, Anton R, Amrikachi M. Clinical outcomes for “suspicious” category in thyroid fine-needle aspiration biopsy: patient’s sex and nodule size are possible predictors of malignancy. Arch Pathol Lab Med. 2009;133(5):787–790. doi:10.5858/133.5.78719415954
   PubMed Web of Science ®Google Scholar
• Frates MC, Benson CB, Doubilet PM, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91(9):3411–3417. doi:10.1210/jc.2006-069016835280
   PubMed Web of Science ®Google Scholar
• Mendelson AA, Tamilia M, Rivera J, et al. Predictors of malignancy in preoperative nondiagnostic biopsies of the thyroid. J Otolaryngol Head Neck Surg. 2009;38(3):395–400.19476774
   PubMed Web of Science ®Google Scholar
• Zhao S, Jia X, Fan X, et al. Association of obesity with the clinicopathological features of thyroid cancer in a large, operative population: a retrospective case-control study. Medicine (Baltimore). 2019;98(50):e18213. doi:10.1097/MD.000000000001821331852078
   PubMed Web of Science ®Google Scholar
• Jankovic B, Le KT, Hershman JM. Clinical Review: hashimoto’s thyroiditis and papillary thyroid carcinoma: is there a correlation? J Clin Endocrinol Metab. 2013;98(2):474–482. doi:10.1210/jc.2012-297823293329
   PubMed Web of Science ®Google Scholar
• Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H. Is Hashimoto’s thyroiditis a risk factor for papillary thyroid cancer? J Surg Res. 2008;150(1):49–52. doi:10.1016/j.jss.2007.09.02017996901
   PubMed Web of Science ®Google Scholar
• Lai X, Xia Y, Zhang B, Li J, Jiang Y. A meta-analysis of Hashimoto’s thyroiditis and papillary thyroid carcinoma risk. Oncotarget. 2017;8(37):62414–62424. doi:10.18632/oncotarget.1862028977955
   PubMedGoogle Scholar
• Resende de Paiva C, Gronhoj C, Feldt-Rasmussen U, von Buchwald C. Association between hashimoto’s thyroiditis and thyroid cancer in 64,628 patients. Front Oncol. 2017;7:53. doi:10.3389/fonc.2017.0005328443243
   PubMed Web of Science ®Google Scholar
• He LZ, Zeng TS, Pu L, Pan SX, Xia WF, Chen LL. Thyroid hormones, autoantibodies, ultrasonography, and clinical parameters for predicting thyroid cancer. Int J Endocrinol. 2016;2016:8215834. doi:10.1155/2016/821583427313612
   PubMed Web of Science ®Google Scholar
• Adhami M, Michail P, Rao A, et al. Anti-thyroid antibodies and TSH as potential markers of thyroid carcinoma and aggressive behavior in patients with indeterminate fine-needle aspiration cytology. World J Surg. 2020;44(2):363–370. doi:10.1007/s00268-019-05153-131502005
   PubMed Web of Science ®Google Scholar
• Kim ES, Lim DJ, Baek KH, et al. Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid. 2010;20(8):885–891. doi:10.1089/thy.2009.038420465529
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhou Q, Xu Y, Yuan SL, Liu QA. Positive thyroid antibodies and risk of thyroid cancer: a systematic review and meta-analysis. Mol Clin Oncol. 2019;11(3):234–242. doi:10.3892/mco.2019.188631341621
   PubMed Web of Science ®Google Scholar
• Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer. 2006;106(3):524–531. doi:10.1002/cncr.2165316369995
   PubMed Web of Science ®Google Scholar
• Tessler FN, Middleton WD, Grant EG. Thyroid Imaging Reporting and Data System (TI-RADS): a User’s Guide. Radiology. 2018;287(3):1082. doi:10.1148/radiol.2018184008
   PubMed Web of Science ®Google Scholar
• Smith JJ, Chen X, Schneider DF, et al. Cancer after thyroidectomy: a multi-institutional experience with 1523 patients. J Am Coll Surg. 2013;216(4):571–577; discussion 577–579. doi:10.1016/j.jamcollsurg.2012.12.022
   Web of Science ®Google Scholar
• Rago T, Fiore E, Scutari M, et al. Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. Eur J Endocrinol. 2010;162(4):763–770. doi:10.1530/EJE-09-089520083557
   PubMed Web of Science ®Google Scholar
• Luo J, McManus C, Chen H, Sippel RS. Are there predictors of malignancy in patients with multinodular goiter? J Surg Res. 2012;174(2):207–210. doi:10.1016/j.jss.2011.11.103522341348
   PubMed Web of Science ®Google Scholar
• Liu J, Zheng D, Li Q, et al. A predictive model of thyroid malignancy using clinical, biochemical and sonographic parameters for patients in a multi-center setting. BMC Endocr Disord. 2018;18(1):17. doi:10.1186/s12902-018-0241-729514621
   PubMed Web of Science ®Google Scholar
• Girardi FM, Silva LMD, Flores CD. A predictive model to distinguish malignant and benign thyroid nodules based on age, gender and ultrasonographic features. Braz J Otorhinolaryngol. 2019;85(1):24–31. doi:10.1016/j.bjorl.2017.10.00129162407
   PubMed Web of Science ®Google Scholar
• Witczak J, Taylor P, Chai J, et al. Predicting malignancy in thyroid nodules: feasibility of a predictive model integrating clinical, biochemical, and ultrasound characteristics. Thyroid Res. 2016;9:4. doi:10.1186/s13044-016-0033-y27313663
   PubMedGoogle Scholar
• Ito Y, Hirokawa M, Fukushima M, et al. Occult papillary thyroid carcinoma: diagnostic and clinical implications in the era of routine ultrasonography. World J Surg. 2008;32(9):1955–1960. doi:10.1007/s00268-008-9614-918594906
   PubMed Web of Science ®Google Scholar